Timely eradication of HCV viremia by PegIFN/RBV is crucial in prevention of post RFA recurrence in CHC-HCC patients.

CONCLUSIONS: Timely treatment with SVR achievement has the lowest tumor recurrence rate in CHC-HCC patients. Secondary prevention might be even more important than tertiary prevention in CHC patients, especially regarding prevention of post RFA HCC recurrence. PMID: 30581103 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30581103?dopt=Abstract

Source: J Formos Med Assoc - December 20, 2018 Category: General Medicine Authors: Chen YC, Teng W, Hsieh YC, Chen WT, Jeng WJ, Huang CH, Lin CC, Chen YC, Lin SM, Lin CY, Sheen IS Tags: J Formos Med Assoc Source Type: research